Spire Healthcare Group plc (LON:SPI)
| Market Cap | 643.36M -12.8% |
| Revenue (ttm) | 1.58B +4.5% |
| Net Income | 16.40M -35.4% |
| EPS | 0.04 -35.5% |
| Shares Out | 400.60M |
| PE Ratio | 40.15 |
| Forward PE | 20.06 |
| Dividend | 0.02 (0.91%) |
| Ex-Dividend Date | May 21, 2026 |
| Volume | 1,218,171 |
| Average Volume | 1,319,294 |
| Open | 163.00 |
| Previous Close | 164.00 |
| Day's Range | 159.40 - 165.00 |
| 52-Week Range | 140.80 - 256.50 |
| Beta | 0.91 |
| RSI | 47.18 |
| Earnings Date | Jul 30, 2026 |
About Spire Healthcare Group
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It operates in two segments: Hospitals Business and Primary Care. The company provides diagnostics, inpatient, day case, and outpatient care in areas, including orthopedics, gynaecology, cardiology, neurology, oncology, and general surgery; and primary care needs of outpatients, such as GP services, occupational health services, and mental and physical health services. It also offers various treatments in the areas ... [Read more]
Financial Performance
In 2025, Spire Healthcare Group's revenue was 1.58 billion, an increase of 4.54% compared to the previous year's 1.51 billion. Earnings were 16.40 million, a decrease of -35.43%.
Financial StatementsNews
Spire Healthcare Share Price Is Down 38% From Its Peak — But the Business Keeps Growing
You can get a visceral sense of what the company does and why it matters to the people who use it by walking through the reception of any Spire Healthcare hospital, such as the Spire Manchester Hospit...
Spire Healthcare Group PLC (LSE:SPI) Full Year 2025 Earnings Call Highlights: Navigating Growth ...
Spire Healthcare Group PLC (LSE:SPI) Full Year 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges
Full Year 2025 Spire Healthcare Group PLC Earnings Call Transcript
Full Year 2025 Spire Healthcare Group PLC Earnings Call Transcript
Spire Healthcare Group Earnings Call Transcript: H2 2025
Revenue grew 4.5% with strong private and primary care momentum, while NHS volumes slowed due to budget constraints. Adjusted EBITDA rose 3.2% and free cash flow surged 65%, supported by £30m in transformation savings. NHS uncertainty remains a key risk for 2026.
UK’s biggest private hospital provider Spire in talks on sale to private equity
Shares in FTSE 250 company jump as it reveals Bridgepoint and Triton are among groups interested in takeover Business live – latest updates The UK’s biggest private hospital provider, Spire Healthcare...
UK Stock Market News: Big Yellow, Spire Healthcare, Mony Group
Business rate impact update from Big Yellow, Spire Healthcare guides FY forecasts lower, Mony Group sees FY25 on track, headwinds abating
Half Year 2025 Spire Healthcare Group PLC Earnings Call Transcript
Half Year 2025 Spire Healthcare Group PLC Earnings Call Transcript
Spire Healthcare soars as it goes up for sale
The update pushed shares up more than 18 per cent in early trading before it closed 14.1 per cent, or 31p, up at 247p.
Hospital operator Spire considering potential sale
Shares in FTSE 250 firm Spire Healthcare shot higher on Friday morning after it confirmed it would consider options including a sale.
European Stocks Rise; SPIRE HEALTHCARE (SPI) Gains on Sale Speculation
European Stocks Rise; SPIRE HEALTHCARE (SPI) Gains on Sale Speculation
Private hospitals group Spire faces investor calls to explore sale
Spire Healthcare, the private hospitals operator, is facing calls from leading investors to put itself up for sale.
Spire Healthcare Group Earnings Call Transcript: H1 2025
H1 results met guidance with 4.9% revenue growth and 2.8% higher adjusted EBITDA, driven by efficiency savings and strategic transformation. NHS and primary care segments showed strong growth, while private volumes faced headwinds. Full-year outlook remains in line with expectations.
Spire Healthcare Group Transcript: Status Update
Primary care is a major growth focus, targeting £40 million EBITDA through organic expansion, new services, and M&A, with strong NHS contract visibility and a CapEx-light model. Service integration, digital delivery, and a data-driven approach underpin operational efficiency and market reach.
Spire Healthcare Group Earnings Call Transcript: H2 2024
Full-year 2024 results showed strong revenue and margin growth, with adjusted EBITDA up 9% and all core metrics meeting guidance. Efficiency programs are ahead of plan, offsetting significant cost pressures, and the outlook remains positive for mid-single-digit growth in 2025.
Meet the private healthcare boss who’s ‘proud the NHS exists’
Justin Ash’s Spire Healthcare makes millions from hip ops and therapy and wants to expand further – but only in a ‘complementary’ way to the state provider In a 1980s redbrick building near Gatwick ai...
Spire Healthcare: invest in the booming demand for private healthcare
Spire Healthcare is one of the few listed companies benefiting from the growing trend in private healthcare. Should you invest?
Spire Healthcare reports profit and revenue jump as its work for NHS increases
Private hospital group also benefited from higher take-up of private health insurance among working-age people Spire Healthcare, one of the UK’s biggest private hospital groups, has reported a jump in...
Spire Healthcare Group Earnings Call Transcript: H1 2024
Strong H1 2024 results with revenue up 12.7% and adjusted EBITDA up 10.8%, driven by PMI and NHS growth, margin expansion, and successful integration of Vita. Cost savings and efficiency programs are on track, supporting unchanged full-year guidance and positive medium-term outlook.